Latest Articles
- Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination
- Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using 90Y-NM600 in combination with androgen deprivation therapy in murine prostate tumors
- Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models
- Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade
- Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials
POPULAR ARTICLES
- Case report
- Position article and guidelines
- Immune cell therapies and immune cell engineering
- Clinical/translational cancer immunotherapy
- Commentary